Mingru Yin

Mingru Yin

Auto-generated profile, based on publicly available information

Mingru Yin

Department of Assisted Reproduction, Shanghai Ninth People’s Hospital Affiliated to JiaoTong University School of Medicine , Shanghai

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LWLi Wang
Li Wang
MYMingru Yin
Mingru Yin
YLYali Liu
Yali Liu
qiuju chenqiuju chen
qiuju chen
YWYun Wang
Yun Wang
Yanping KuangYanping Kuang
Yanping Kuang
Among women undergoing IVF, high BMI negatively affects pregnancy outcomes when using the conventional ovary stimulating protocols combined with fresh embryo transfer. Therefore, finding a proper treatment for these high BMI women is more important and urgent when obesity is prevalent. In our study, we reported a retrospective study of 4457 women who were divided into normal BMI group (18.5 kg/m2–24.9 kg/m2) and high BMI group (≥25 kg/m2) undergoing 4611 IVF treatment cycles with frozen embryo transfer (FET). We found the high BMI group originally had the poor oocytes performance, but after FET they got the similar pregnancy outcomes as the normal BMI group. Then under FET we analyzed the IVF outcomes of our new progestin-primed ovary stimulation (PPOS) protocol, indicating that the hMG + MPA (4 or 10 mg/d) groups had the obvious better pregnancy results than the conventional short group in the high BMI group, and binary logistic regression analysis showed the hMG + MPA (10 mg/d) group was associated with better pregnancy outcomes than the hMG + MPA (4 mg/d) group. These results indicate PPOS - hMG + MPA (10 mg/d) combined with FET might be a new potential treatment choice for the high BMI women undergoing IVF treatments.

4 November 2021 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
MYMingru Yin
Mingru Yin
WYWeina Yu
Weina Yu
WLWenzhi Li
Wenzhi Li
QZQianqian Zhu
Qianqian Zhu
HLHui Long
Hui Long
QLQifeng Lyu
Qifeng Lyu
Background: The application of artificial oocyte activation (AOA) after intracytoplasmic sperm injection (ICSI) is successful in mitigating fertilization failure problems in assisted reproductive technology (ART). Nevertheless, there is no relevant study to investigate whether AOA procedures increase developmental risk by disturbing subsequent gene expression at different embryonic development stages. Methods: We used a mouse model to explore the influence of AOA treatment on pre- and post-implantation events. Firstly, the developmental potential of embryos with or without AOA treatment were assessed by the rates of fertilization and blastocyst formation. Secondly, transcriptome high-throughput sequencing was performed among the three groups (ICSI, ICSI-AOA and dICSI-AOA groups). The hierarchical clustering and Principal Component Analysis (PCA) analysis were used. Subsequently, Igf2r/Airn methylation analysis were detected using methylation-specific PCR sequencing following bisulfite treatment. Finally, birth rate and birth weight were examined following mouse embryo transfer. Results: The rates of fertilization and blastocyst formation were significantly lower in oocyte activation-deficient sperm injection group (dICSI group) when compared with the ICSI group (30.8 % vs. 84.4 %, 10.0 % vs. 41.5 %). There were 133 differentially expressed genes (DEGs) between the ICSI-AOA group and ICSI group, and 266 DEGs between the dICSI-AOA group and ICSI group. In addition, the imprinted gene, Igf2r is up regulated in AOA treatment group compared to control group. The Igf2r/Airn imprinted expression model demonstrates that AOA treatment stimulates maternal allele-specific mehtylation spreads at differentially methylated region 2, followed by the initiation of paternal imprinted Airn long non-coding (lnc) RNA, resulting in the up regulated expression of Igf2r. Furthermore, the birth weight of newborn mice originating from AOA group was significantly lower compared to that of ICSI group. The pups born following AOA treatment did not show any other abnormalities during early development. All offspring mated successfully with fertile controls. Conclusions: AOA treatment affects imprinted gene Igf2r expression and mehtylation states in mouse pre- and post-implantation embryo, which is regulated by the imprinted Airn. Nevertheless, no significant differences were found in post-natal growth of the pups in the present study. It is hoped that this study could provide valuable insights of AOA technology in assisted reproduction biology.

7 May 2021 in Andrology
Verified
Journal Article
Closed access
PDF file
PKPengcheng Kong
Pengcheng Kong
YLYanan Liu
Yanan Liu
QZQianqian Zhu
Qianqian Zhu
MYMingru Yin
Mingru Yin
XTXiaoming Teng
Xiaoming Teng

30 September 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
PKPengcheng Kong
Pengcheng Kong
JPJiaping Pan
Jiaping Pan
SLShanshan Liang
Shanshan Liang
MYMingru Yin
Mingru Yin
XTXiaoming Teng
Xiaoming Teng
Research question: Does the presence of smooth endoplasmic reticulum aggregates (SERa) in oocytes adversely impact the euploidy rate of subsequent blastocysts?Design: We performed a retrospective cohort study with 671 young patients (< 38 years) undergoing their first preimplantation genetic testing for aneuploidy (PGT-A) between January 2019 and October 2022 at a reproductive medical center of university affiliated teaching hospitals in China. Cycles were categorized as either SERa(+) cycles (containing at least one SERa(+) oocyte) or SERa(-) cycles (all oocytes without SERa). In SERa(+) cycles, oocytes were further subdivided into the SERa(+) oocyte group and the sibling SERa(-) oocyte group, comprising oocytes with normal morphology.Results: No significant differences were observed in the normal fertilization rate (72.9% vs. 75.4% vs. 72.6%, P=0.343), and cleavage rate (96.8% vs. 97.1% vs. 96.4%, P=0.839) among the SERa(-) cycle group, the SERa(-) oocyte group, and the SERa(+) oocyte group. Additionally, there were no statistically significant differences in the rates of good quality embryos (44.7% vs. 48.8% vs. 46.2%, P=0.177) or blastocyst formation (60.1% vs. 60.9% vs. 60.5%, P=0.893) among the groups. However, the euploidy rate of blastocysts derived from SERa(+) oocytes was significantly lower compared to those from SERa(-) oocytes in SERa(+) cycles and normal oocytes in SERa(-) cycles (39.3% vs. 51.2% vs. 54.5%, P=0.005). Despite this, there were no significant differences in pregnancy and neonatal outcomes after euploid embryo transfer among the three groups.Conclusions: Blastocysts derived from SERa(+) oocytes have a lower euploidy rate than those derived from SERa(-) oocytes. Nevertheless, comparable reproductive outcomes were achieved following euploid embryo transfer from both SERa(+) and SERa(-) oocytes.

27 September 2020 in Human Reproduction
Verified
Journal Article
Open access
JLJianghui Li
Jianghui Li
MYMingru Yin
Mingru Yin
BWBian Wang
Bian Wang
QZQianqian Zhu
Qianqian Zhu

16 July 2025 in Human Reproduction
Verified
Journal Article
Closed access
JLJiaying Lin
Jiaying Lin
QCQiuju Chen
Qiuju Chen
YHYining He
Yining He
MYMingru Yin
Mingru Yin
QZQianqian Zhu
Qianqian Zhu
STUDY QUESTION: Does female or male hepatitis B virus (HBV) infection affect the oocyte and embryo quality, pregnancy outcomes, and neonatal outcomes in infertile couples undergoing ART treatment? SUMMARY ANSWER: The female or male HBV infection did not have a statistically significant negative impact on the development of oocytes and embryos, pregnancy outcomes, or neonatal outcomes of ART. WHAT IS KNOWN ALREADY: Only few studies assessing the effects of HBV infection on the reproductive outcomes among infertile population have been conducted with inconsistent results. There is limited research that focuses on the oocyte and embryo development of HBV-infected females and males. STUDY DESIGN, SIZE, DURATION: A retrospective cohort study was performed among infertile couples undergoing the first frozen embryo transfer (FET) after the first ovarian stimulation with a freeze-all strategy during the period from 1 January 2011 to 31 March 2023. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 24 836 infertile couples, including 133 couples with female HBV-positive and male HBV-negative, 1471 couples with female HBV-negative and male HBV-positive, and 23 232 couples with both female and male HBV-negative underwent their first FET after the first ovarian stimulation with a freeze-all strategy. Propensity score matching (PSM) was used to balance the baseline parameters between the groups. MAIN RESULTS AND THE ROLE OF CHANCE: After PSM, no statistically significant differences were observed regarding the comparison in the number of oocytes retrieved, MII oocytes, 1-2-3 PN-fertilized oocytes, 2PN-fertilized oocytes, embryo cleavages, available embryos, top-quality embryos, and available blastocysts between comparison groups (group with female HBV-positive and male HBV-negative and group with female HBV-negative and male HBV-positive) and the reference group. Consistently, the differences in the mature oocyte rate, fertilization rate, cleavage rate, as well as top-quality embryo rate and available embryo rate between comparison groups and the reference group were not statistically significant. The clinical pregnancy rate and the live birth rate showed a decreasing trend for couples with female HBV infection compared with the uninfected couples, although this did not reach statistical significance (clinical pregnancy: adjusted odds ratio, 0.69 [95% CI: 0.45–1.05] and live birth: 0.64 [0.41–1.00]). Couples with female HBV infection and couples with male HBV infection were not associated with increased risk of adverse neonatal outcomes including preterm birth, low birth weight, high birth weight, small for gestational age, and large for gestational age. LIMITATIONS, REASONS FOR CAUTION: This was a retrospective cohort study in a single center, which limited the generalization of our results. WIDER IMPLICATIONS OF THE FINDINGS: HBV infection was not statistically significantly associated with development of oocyte and embryo quality, pregnancy outcomes, and neonatal outcomes. These findings indicate infertile women or male with HBV infection should not be prevented from seeking ART due to concerns about negative effects. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the National Natural Science Foundation of China (grant nos. 82273634, 81903324), the interdisciplinary program of Shanghai Jiao Tong University (YG2019QNA19), and the second round of Promoting clinical skills and clinical innovation in municipal hospitals New three-year Action Plan “Research physicians innovation and transformation ability Strength training program” (SHDC2023CRS031). There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.